Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Andes Pediatr ; 92(1): 93-98, 2021 Feb.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-34106188

RESUMO

INTRODUCTION: Fusobacterium nucleatum is an anaerobic bacillus that is part of the oral microbiota and dental pla que. This can cause local and potentially remote infections, which are exceptional in pediatrics. Ob jective: To present the case of a patient with lung injury with chest wall invasion by Fusobacterium nucleatum. CLINICAL CASE: An 11-year-old female immunocompetent patient who consulted due to a two-week history of cough, night sweats, without fever or weight loss, and increased volume at the left spleen thoracic level. There was no history of chest wall trauma or travel outside the country. Two weeks before the onset of symptoms, she was treated for dental caries. Imaging studies and CT scan showed left spleen pneumonia, which invades the pleura and the chest wall. A minimal thoracotomy was performed, releasing a thick, foul-smelling liquid. The studies for common germs and tubercu losis were negative. Hematology ruled out tumor lesions. The anaerobic study reported the develo pment of Fusobacterium nucleatum. The patient was treated with penicillin followed by amoxicillin presenting good clinical and radiological responses. The dental procedure was suspected as the cause of infection. CONCLUSIONS: Fusobacterium nucleatum can occasionally cause remote or extra-oral in fections in immunocompetent patients, such as pneumonia with chest wall invasion, therefore it is necessary to bear it in mind.


Assuntos
Infecções por Fusobacterium , Fusobacterium nucleatum/isolamento & purificação , Pneumonia Bacteriana/microbiologia , Amoxicilina/uso terapêutico , Antibacterianos/uso terapêutico , Criança , Cárie Dentária/complicações , Cárie Dentária/terapia , Feminino , Infecções por Fusobacterium/diagnóstico por imagem , Infecções por Fusobacterium/tratamento farmacológico , Infecções por Fusobacterium/cirurgia , Humanos , Penicilinas/uso terapêutico , Pneumonia Bacteriana/diagnóstico por imagem , Pneumonia Bacteriana/tratamento farmacológico , Pneumonia Bacteriana/cirurgia , Parede Torácica/microbiologia , Toracotomia
2.
Rev Med Chil ; 133(4): 419-25, 2005 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-15953948

RESUMO

BACKGROUND: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. AIM: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. MATERIAL AND METHODS: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. RESULTS: All strains were sensible to telithromycin at a concentration -4 microg/ml. MIC 90 and its range for SPNS was 0.03 microg/ml (-0.004-0.12), for SPNI was 0.03 microg/ml (-0.004-025), for SPNR was 0.06 microg/ml (-0.004-0.25), for HIN was 2 microg/ml (0.12-4), for SP was 0.5 microg/ml (-0.004-2), for MC was 0.5 microg/ml (0.06-2) and for SAU was 0.25 microg/ml (0.06-0.25). CONCLUSIONS: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections.


Assuntos
Antibacterianos/farmacologia , Cetolídeos/farmacologia , Infecções Respiratórias/tratamento farmacológico , Infecções Estreptocócicas/tratamento farmacológico , Infecções Comunitárias Adquiridas/tratamento farmacológico , Farmacorresistência Bacteriana , Haemophilus influenzae/efeitos dos fármacos , Humanos , Técnicas In Vitro , Testes de Sensibilidade Microbiana , Moraxella catarrhalis/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pyogenes/efeitos dos fármacos
3.
Rev. méd. Chile ; 133(4): 419-425, abr. 2005. ilus
Artigo em Espanhol | LILACS | ID: lil-417379

RESUMO

Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration ¡4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (¡0.004-0.12), for SPNI was 0.03 µg/ml (¡0.004-025), for SPNR was 0.06 µg/ml (¡0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (¡0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections.


Assuntos
Humanos , Antibacterianos/farmacologia , Infecções Respiratórias/tratamento farmacológico , Infecções Comunitárias Adquiridas/tratamento farmacológico , Streptococcus pneumoniae , Streptococcus pyogenes
4.
Rev. méd. Chile ; 118(8): 841-5, ago. 1990. tab
Artigo em Espanhol | LILACS | ID: lil-96551

RESUMO

A toxonomic study of 82 strains of Staphylococci and 6 reference samples isolated from clinical cases was carried out. Results of 47 phenotype tests were submitted to a numerical analysis using the similarity coefficient of Sokal and Michener and a grouping technique (UPGMA). Based on a 75 similarity level, 4 phenons were identified. 37 strains identified as S aureus were grouped in phenon A; 32 strains of S hominis in phenon B; 5 strains of S epidermidis in phenon C and 8 strains of S ssp in phenon D


Assuntos
Staphylococcus/classificação , Técnicas In Vitro , Manejo de Espécimes , Staphylococcus/isolamento & purificação , Infecção Hospitalar , Técnicas Bacteriológicas
5.
Rev. chil. pediatr ; 60(3): 173-8, mayo-jun. 1989. ilus
Artigo em Espanhol | LILACS | ID: lil-67813

RESUMO

Se presenta una niña de 14 años con actinomicosis torácica. Se destaca la rara incidencia de esta enfermedad en la edad pediátrica y las dificultades para hacer el diagnóstico. La presencia de una lesión pulmonar de larga evolución, junto a lesiones osteomielíticas de varias costillas y posterior fistulización a la pared costal, con eliminación de los característicos "gránulos de azufre" fueron los elementos claves para sospechar la causa de la enfermedad. Se confirmó el diagnóstico por estudio bacteriológico e histológico. La paciente se trató con dosis altas de penicilina, evolucionando en forma favorable


Assuntos
Adolescente , Humanos , Feminino , Actinomicose/patologia , Actinomicose/diagnóstico , Actinomicose/tratamento farmacológico , Fístula , Penicilinas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...